BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 9697397)

  • 1. [Mycophenolate mofetil].
    Abramowicz D; Broeders N; Wissing M; Sternon J
    Rev Med Brux; 1998 Jun; 19(3):139-43. PubMed ID: 9697397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group.
    Lancet; 1995 May; 345(8961):1321-5. PubMed ID: 7752752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
    Transplantation; 1996 Apr; 61(7):1029-37. PubMed ID: 8623181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of leukopenia and cytomegalovirus disease in kidney transplants treated with mycophenolate mofetil combined with low cyclosporine and steroid doses.
    Moreso F; Serón D; Morales JM; Cruzado JM; Gil-Vernet S; Pérez JL; Fulladosa X; Andrés A; Grinyó JM
    Clin Transplant; 1998 Jun; 12(3):198-205. PubMed ID: 9642510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial comparing two corticosteroid regimens combined with mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection.
    Juarez FJ; Barrios Y; Cano L; Lopez E; Martinez J; Limones M; Adalid C; Soria N; Medina JL
    Transplant Proc; 2006 Nov; 38(9):2866-8. PubMed ID: 17112851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. The Mycophenolate Mofetil Renal Refractory Rejection Study Group.
    Transplantation; 1996 Mar; 61(5):722-9. PubMed ID: 8607174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial. European Mycophenolate Mofetil Cooperative Study Group.
    Transplantation; 1999 Aug; 68(3):391-6. PubMed ID: 10459543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate mofetil--a new immunosuppressant for organ transplantation.
    Med Lett Drugs Ther; 1995 Sep; 37(958):84-6. PubMed ID: 7674993
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of mycophenolate mofetil in kidney transplantation].
    Hrvacevic R; Ignjatovic Lj; Vavic N
    Vojnosanit Pregl; 2001; 58(4):415-9. PubMed ID: 11712223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate mofetil in liver transplantation.
    McDiarmid SV
    Clin Transplant; 1996 Feb; 10(1 Pt 2):140-5. PubMed ID: 8680052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of clinical experience with the novel immunosuppressive drug mycophenolate mofetil in renal transplantation.
    Behrend M
    Clin Nephrol; 1996 May; 45(5):336-41. PubMed ID: 8738667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AcylMPAG plasma concentrations and mycophenolic acid-related side effects in patients undergoing renal transplantation are not related to the UGT2B7-840G>A gene polymorphism.
    van Agteren M; Armstrong VW; van Schaik RH; de Fijter H; Hartmann A; Zeier M; Budde K; Kuypers D; Pisarski P; Le Meur Y; van der Werf M; Mamelok RD; Oellerich M; van Gelder T
    Ther Drug Monit; 2008 Aug; 30(4):439-44. PubMed ID: 18641546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the safety and efficacy of mycophenolate mofetil, prednisolone and cyclosporine and conventional cyclosporine and prednisolone in kidney transplantation.
    Kim HC; Park SB; Kim HT; Cho WH; Park CH
    Transplant Proc; 2000 Nov; 32(7):1751-2. PubMed ID: 11119919
    [No Abstract]   [Full Text] [Related]  

  • 14. Mycophenolate mofetil for maintenance therapy in kidney transplantation.
    Gonwa TA
    Clin Transplant; 1996 Feb; 10(1 Pt 2):128-30. PubMed ID: 8680049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolate mofetil, along with ATG and cyclosporine, significantly lowers the incidence of acute rejection episodes in renal transplant recipients.
    Puig JM; Lloveras J; Fernández-Crespo P; Mir M; Iñigo V; Manresa JM; Masramón J
    Transplant Proc; 1999 Sep; 31(6):2259-60. PubMed ID: 10500567
    [No Abstract]   [Full Text] [Related]  

  • 16. Mycophenolate mofetil in pediatric renal transplantation.
    Weber LT; Höcker B; Mehls O; Tönshoff B
    Minerva Urol Nefrol; 2003 Mar; 55(1):91-9. PubMed ID: 12773970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the role for mycophenolate mofetil in pediatric renal transplantation?
    Neu AM; Benfield M
    Pediatr Transplant; 1999 Feb; 3(1):83-7. PubMed ID: 10359037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil.
    Sollinger HW
    Kidney Int Suppl; 1995 Dec; 52():S14-7. PubMed ID: 8587275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil in renal transplantation: results from the U.S. randomized trials.
    Danovitch GM
    Kidney Int Suppl; 1995 Dec; 52():S93-6. PubMed ID: 8587293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate mofetil: suggested guidelines for use in kidney transplantation.
    Behrend M
    BioDrugs; 2001; 15(1):37-53. PubMed ID: 11437674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.